| Name | Title | Contact Details |
|---|
CancerConsultants.com is a Ketchum, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Camp Gladiator is more than a fitness boot camp, it`s an experience. Created by American Gladiator Grand Champion Ally Davidson, Camp Gladiator has become the fastest growing and most dynamic fitness program in the nation.
Stonegate Community Health Centre is a Etobicoke, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Helen Keller Hospital is a not-for-proft, community hospital in Sheffield, AL. An acute care facility, Helen Keller Hospital is licensed to operate 185 beds. History Colbert County and the City of Sheffield opened a Hospital, March 22, 1921. At the time, this was called Colbert County Hospital. It is now known as Helen Keller Memorial Hospital, part of the Colbert County Healthcare Authority. Other healthcare entities under the umbrella the Colbert County Healthcare Authority include Red Bay Hospital, North Alabama Sleep Disorders Center and Northwest Practice Management. On May 21, 1979, the name of the hospital was changed to Helen Keller Hospital in honor of that great lady and world-renowned humanitarian. The continued growth of the Northwest Alabama Healthcare Authority is a result of the dedication of the Board of Trustees, the citizens of Colbert County and the hospital employees, who deliver excellent patient care. Helen Keller Hospital is fully accredited by the Joint Commission on Accreditation of Hospitals assuring the finest in medical care by the process of review inspection and updating. The Authority is governed by a nine-member Board of Trustees from Colbert County appointed by the County Commission serving in staggered six-year terms. While the Board of Trustees is ultimately responsible for the operation of the Authority, the details are delegated to the Authority President.
Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Abeona’s lead program is an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. Clinical trials for Sanfilippo types A and B are anticipated to begin in 2015.